Senosis uses smartphones as monitoring devices to collect health data capable of diagnosing conditions like pulmonary function and hemoglobin counts. The company’s apps — like SpiroSmart, SpiroCall, HemaApp and OsteoApp — are awaiting Food and Drug Administration approval, according to The Inquirer.
Shwetak Patel, PhD, a computer scientist at Seattle-based University of Washington who cofounded Senosis, declined comment to GeekWire. Representatives from Google were not immediately available for comment, according to GeekWire.
More articles on health IT:
Fired Google employee strikes back, says Google is like a ‘cult’
Kaspersky: Malware disguised as ransomware will pose problems in Q3
HIMSS Analytics expands health IT market database with international data
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.